Not possible due to IB buying back shorts, 8M shares traded since the start of rally from 4.20pm, there is not that many shorting shares as of 30th Dec Bursa record as Supermax is not in the list. But if you say it is window dressing, that might make a little more sense.
Anyway, as long as SPMX can prove that it will sustain at least 400 - 500M QR post Covid, there's no need of all these tricks. It'll shoot like rocket.

@CharlesT @Jasoonlim, FTS sifu is talking about facts. Nobody hopes for vaccine to not working. But the thing is reality is reality, it won't answer to your prayers or curses, it just happen when it deems fit when all conditions are met. The threat is still there and it won't disappear just because someone shout the prayers loud or vaccine started rolling out prematurely. Seriously, there are still a lot of doubts that even the vaccine makers can't answer, like what are the long term side effects? When can herd immunity be achieved? If all doubts are cleared, then the last question I would ask is why the vaccine makers requested to indemnify themselves? Are they not confident enough with their own products? I guess nobody can answer the above.

@ToneeFa, actually the price broke 6 today doesn't mean it broke the support of 6. Because the buying queue is at millions at 5.98 when closing, means support is still strong. Only thing is dumping happened all of a sudden during last 3 mins of trading today and people don't have time to react. Let's see what's going to happen tomorrow. Good night.

TSLIM already put in multi-millions of his own wealth into his own company believing the future of gloves to outshine anything else. If gloves is really going into oversupply issue, and company value would be cut half, do you think he would still do this to his own money?

Everyone is talking like they know more than the gloves makers... what a shame.

when Astrazeneca vaccines news out, gloves counters in China and Thailand flying higher, but Malaysia's laggard. with this you know someone is playing the dirty cards behind in Bursa.

@Runfirst - most CW due in Feb onwards are out of money and most of them are not issued. thus no meaning for continuous pressing, since there is no benefit. Only shares going up the issuer are able to sell their CW.

the buy sell fight is getting fierce today.

@Goldgent, MRDIY need to rise until 25th place, before it can replace any KLCI constituent stock.
It's not that easy given many CWs will be due in May-June.

@gemfinder, Supermax is SMETA compliant and a member of SEDEX. So to debunk your false claim of force labor in Supermax.

@gemfinder, the culprits are those big middle man selling gloves in developed countries, they are the ones compressing gloves margin all the time. Don't blame on manufacturers.

@stockraider, 9 months into pandemic, glove price still at it's peak. Don't compare with mask as it is totally different. If it so simple to make gloves the price wouldn't have still at current level. Which new comer has started their glove production 9 months since pandemic started, tell me.
*insas dividend can't even fight topglove, what a joke.

@gemfinder, enough said. Dr. Fauci now revised his view that 90% of population must be inoculated to reach herd immunity. Think about, when will herd immunity be achieved?

Gloves new comers be worried. Gloves manufacturing is not masak masak.

英科医疗(SZ300677)$ 

其实手套制造过程是一种不稳定的过程，这一点对制造业来说是极难的。
在制造业领域，很多事情都是可以积累的，比如加工精度、比如加工速度等，一旦技术上突破了，就可以积累，然后让制造能力稳定在一个水平。但是手套制造并不是这样的，他的产线速度、手套的克重、成品率等核心制造指标往往会因温度、杂质、速度等差异出现不稳定的状态，因而手套制造的学习曲线相当长，往往并不是一两、两年就能快速掌握并持续提升的。
这玩意儿就如同踢足球或打蓝球，是团队问题，并不是你从贺特佳挖一位工程师或是买一份设计图纸就能够完成的。
生产容易，做好难，特别是行业中已经有了贺特佳、英科这样的老司机的时候，未来的从业者会越来越绝望。

Glovefinish should apologize for providing false information regarding topgloves shares activity. Obviously under new normal for the next 10 years, the most impacted companies will be those under recovery. Now they are just dead cat bounce from vaccine hype. Don't try to trap people to buy into your theory and please talk with logic. The economy is at its worst shape right now and recovery is going to be slow, or else how the heck would government allow EPF withdrawal? But recovery stock almost at pre-covid price. It's totally disconnected. Anyone who is going to buy in be aware.

@teripen, I suggest you to revisit your statement here 6 months and 12 months later too see if your thought still holds then. Maybe you're a short term investor looking for fast gain, i'm not sure.
This pendamic is unprecedented, market may not be right of what's going to happen 6 months or 9 months later, market is not always right, it's just a reflection of what it anticipated based on current news flow. Dr. Fauci just increased the threshold which he thought up to 90% American population to get vaccinated to achieve herd immunity, which means herd immunity may not be able to achieve given having 90% American to get vaccination is harder than place a human to moon. News flow could change and sentiment could change anytime in the next 6 months as things develop and vaccines hype subsides.

3 questions to you:
1) ASP will normalize, everyone knows that, but at what price? Have you thought about that?
2) ASP will normalize at a much higher price for an extended period of time, do you agree?
3) Gloves companies especially with OBM business will reap a sustainable higher earnings due to structural change in distribution/supply chain dynamics, and market had not factor this in as it is still not sure about this. Do you agree?,

You're trying to talk down gloves by sharing fake information of Topglove share activities. That's immoral and illegal.

@Agjl bro, yeah, I reckon it as well. Anyway need someone to clarify so people who read his unjustified claims not be fooled by him.

@glovefinish, please digest a bit the information yoi've received before you used it for your argument. Don't follow blindly what the media says.

@glovefinish, why you tend to believe Chinapress than Bursa announcement itself? Chinapress has made many mistakes in reporting stock news don't you know that? I give you an example. It mentioned today that EPF is selling Topglove shares even on Christmas eve, but truth is, the announcement was made on Christmas eve but the selling was done 3 days ago. The reporter has no knowledge but you choose to follow him. Lol.

The real bubble is recovery stock like AAX etc, those needed to be controlled instead of gloves. AAX's debt has rendered it's share price practically valueless but still many are willing to goreng it with false hope. I think you should look into those stocks instead of gloves.

@glovefinish, when company sell their shares, it must be announced to Bursa and public. Please provide your source from Bursa announcement.

@stockraider, like many have said, whatever goes up will come down, likewise for palm oil CPO. So investors should have factored in one day the CPO price will drop also.

@glovefinish, I'm not sure why you've conveniently ignored the fact that, a large portion of increased profit is due to cutting away middleman. It's one of the irreversible structural changes post-covid, especially for Supermax.

Out of all big 4, Supermax has got no Covid infection till now. This shows their superb corporate governance in view of crisis.

@glovefinish, then it's even more ridiculous, post covid of 1.5-2B is easily >15-20 times pre-covid earnings. Share price only <10 times increase.

IBs have their own agenda. They are not saint. Do you always follow IBs when you invest? Are they always right? I think you have the answer.

@glovefinish, time has proven that gloves moved higher after each outbreak in the past 20 years. And outbreak will not stop here as it is a course of nature.

PPE in the future will not be treated like what they were pre-covid. The serious shortage now is an extremely painful experience for many governments. PPE especially gloves become a strategic product that is linked to national security and public health security. Supermax managment knows this well and their move to US is a brilliant move and will give investors a very fruitful return.

@glovefinish, I'll say it again, higher ASP due to removing of middleman and direct sales of gloves, plus end user price increased 2-3x compared to pre-covid. There's never 10x of end user price compared to pre-covid. So please state your facts right.

@glove finish, i'm not sure where you got the numbers, end-user gloves price were never 10 times higher than pre-covid. If you check out the comments through medical distributors website or Amazon, you'll find that gloves are at most 2-3 times higher than pre-covid. Why ASP increased so much because pre-covid gloves games were dominated by middle man who had huge margins. Now that end-users approached manufacturers directly, the ASP hikes.

Market is very much disturbed by the analyst reports plucking numbers from the sky, thus the bearish sentiment. But who should you trust more? The industry players or the analysts?

@glovefinish, by 2022 Supermax will have 48B capacity excluding US/UK. Even if glove price dropped to USD30-35 they will still be able to earn PAT RM500M/quarter or 2B/year. Go find out how much a company earning PAT 2B/year is worth in Bursa, and it's still a growing manufacturing company, not stagnant like banks.

@glovefinish, like what you said, the bearish trend if gloves is due to sentiment. Sentiment is shortlived and will be beaten by fundamentals. Ultimately it's the earnings that investors are looking for. Gloves will earn more and more in the coming years and Supermax will have the most bullets for business expansion or new business exploration to increase shareholders value.

@glovefinish, downside is very limited given the strong fundamental and sustainable earnings post covid which is much higher than pre-covid.

first try to understand what is CE mark before assessing the importance/significance of this piece of news. https://asq.org/quality-resources/ce-marking

@Teripen, the real winner is the one who see the true value when others don't.

@glovefinish, I'm not talking about the peak, instead I was saying the sustainability of 500M-600M PAT of Supermax when the time comes for normalized ASP, post-covid. 500M-600M is not the peak earning for Supermax, they are able to earn probably 1.5-2B at peak. Not forgetting even if ASP is halved from peak, by that time Supermax's capacity will be more than 2 fold from pre-covid.

@glovefinish, short selling is not a sure-win movement. If the market realized earlier that the earnings of Supermax could sustain for an extended period of time, then the short selling is doomed. Ask yourself, don't you think a 500-600M QR target is an easily sustainable PAT for Supermax in the future? And what should be the market cap to value a growing company for such earnings? Think about longer term, not just a quarter ahead.

@Morpheus, they have the ability to influence the market. For a long term investor and bought the ticket at the right price. Then don't need to care about the short term hoo haa...

Supermax has the highest % free flowing of in-the-money warrant expiring 31st Dec with high premium. That could be the reason. In 2021, most call warrants issued from Sep/Oct 2020 are fully hedged, or conversion ratio is high, also the initial issuing price is high, IB will not do the suppression in 2021. I would say, 2020 is an unprecedented year for gloves counters growth, it's so fast that IBs were not fast enough to catch it. Thus now they need to recoup their losses during low sentiment.

@stockraider, everybody knows the ASP is going to fall eversince the beginning what. Nothing can sustain at the extreme high level. What is there be afraid of? The ASP will eventually normalized to a price significantly higher than pre-pandemic, and supply will not be so soon to catch up. all additional capacity is factored in. If not, u think gloves companies can grow so much in the past 20 years?

@stockraider, gloves usage grow significantly higher after each outbreak. Please check your facts.

@Gloveburst, Genting almost reaching pre-covid level, upside is limited. O&G no future as electric car is coming out and europe and Japan is banning new combustion engine car in 10 years time.

@ibelieve, well said. The JPM's report came with so many flaws which made people wonder what is their true agenda. The analyst signing off the report just joined JPM Aug this year and his LinkedIn acc does not even have a picture of him. I wonder if he's a real person or not.

Many recovery counters had reached almost pre-covid level. Upside is limited. If the economy is recovering well there's no need of EPF withdrawal for the public. Think about it. Certain companies like AA is at very high risk, especially recent share price hike is likely over optimism and there will be a sell down if expectation is not met timely. Even if recovering, huge rights issue may be awaiting.

Swagger855, do you really think the economy could be back to pre-covid situation by 2022? Without herd immunity, and all companies still stay intact and banks will suffer no bad debt risks?

@swagger855, based on your logic, I wonder how glove counters in Malaysia could grow so much in the past 20 years.

@Supersinginvestor, Pfizer said their production next year is 1B doses leh, enough for only 500M ppl. US and Europe alone got >1B ppl, plus Pfizer also supply to other then US and Europe. How do you deduce 70% US Europe got inoculation within 6 months? Moderna 1 year production also only 100M doese a year.